Apollomics (APLM) Goodwill & Intangibles (2020 - 2023)
Apollomics (APLM) posted quarterly Goodwill & Intangibles of $14.8 million for Q2 2023, up 460.43% quarter-over-quarter from -$4.1 million in Q4 2022.
Apollomics (APLM) Goodwill & Intangibles (2020 - 2023) Analysis & Trends
Apollomics (APLM) has reported Goodwill & Intangibles for 4 consecutive years, with $14.8 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Goodwill & Intangibles changed N/A year-over-year to $14.8 million; the TTM figure through Jun 2023 stood at $14.8 million (changed N/A YoY), while the FY2022 annual figure was -$4.1 million, changed 0.49% from the prior year.
- Goodwill & Intangibles improved to $14.8 million in Q2 2023 per APLM's latest filing, from -$4.1 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $14.8 million in Q2 2023 and bottomed at -$4.1 million in Q4 2022.
- Historically, Goodwill & Intangibles has averaged $4.5 million across 4 years, with a median of $3.6 million in 2020.
- Annual changes were most pronounced in 2021 — Goodwill & Intangibles plunged 135.84% — and 2022, when it slipped 0.49%.
- Apollomics' Goodwill & Intangibles stood at $11.4 million in 2020, then slumped by 135.84% to -$4.1 million in 2021, then slipped by 0.49% to -$4.1 million in 2022, then soared by 460.43% to $14.8 million in 2023.
- Business Quant data shows APLM's Goodwill & Intangibles at $14.8 million in Q2 2023, -$4.1 million in Q4 2022, and -$4.1 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Apollomics | 35.18 Mn | 31.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 14.77 Mn |
| Dec 31, 2022 | -4.10 Mn |
| Dec 31, 2021 | -4.08 Mn |
| Dec 31, 2020 | 11.38 Mn |